Practice teaching course at the Fertility Centre Hamburg23-24 September, 2016 - Hamburg, Germany

PRACTICE TEACHING COURSESCIENTIFIC PROGRAmmE

3

OverviewAccording to ESHRE, “crude overall pregnancy rates of 50-65% per patient can be achieved nowadays, irrespective of the type of pro fertility treatment applied first but IVF only accounts for about 20% of the pregnancies achieved. Currently there is no consensus on a single protocol to be preferred to another one”. There is inconsistent knowledge on the application of protocols for controlled ovarian stimulation (COS): hormonal as well as functional and genetic biomarkers, individualized approach to COS or the use of LH in COS. Furthermore, the patients with poor ovarian response represent, even now, one of the most difficult subgroups for ART treatment. Nowadays, a new category of patients based on age and ovarian reserve has been suggested for defining reproductive prognosis and identifying the most appropriate therapeutic strategy. On the other hand, andrology and reproductive genetics may benefit many subgroups of infertile patients concerning their reproductive outcome. Moreover, implementing a quality management system in ART clinics and laboratories plays a key role in improving results. All these aspects may contribute to an increase the success rates in IVF. The aim of this live educational course is to provide new insight into these topics. An interactive programme with lectures followed by discussions and specific case studies will offer attendees up-to-date knowledge and the opportunity to share experiences among peers and experts.

Learning objectivesBy attending this conference, participants will be able to:•Apply evidence-based recommendations to achieve an optimal

management for different subgroups of patients during ART •Identify the most appropriate management of poor responder

and poor prognosis patients •Understand the physiology of LH and its role in ovulation induction •Evaluate the contribution of andrology and reproductive

genetics in improving ART outcome•Recognize the importance of implementing a Quality Management

System and risk management in the ART clinic and laboratory

Practice teaching course at the Fertility Centre Hamburg

4

Target audience This course is designed for a group of clinicians, with at least 5 years of experience, working in assisted reproductive medicine. Due to space limitations in the centre, we suggest a maximum course load of 20 doctors to allow for quality interaction and improved efficiency.

ChairRobert FischerFertility Center HamburgHamburg, Germany

EXCEMED designed this programme in partnership with:

5

Cme ProviderEXCEMED is a non-profit foundation dedicated, since the last four decades, to the development of high-quality medical education programme all over the world.

EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME®) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous.

EXCEMED adheres to the principles of the Good CME Practice group

(gCMEp).

Continuing medical educationAn application has been made to the EACCME® for CME accreditation of the EXCEMED course “IVF Practice teaching course at the Fertility Centre Hamburg” to be held on 23-24 September 2016.

7

Carlo AlviggiFederico II UniversityNaples, Italy

Robert FischerFertility Center HamburgHamburg, Germany

Karsten HeldFertility Center HamburgHamburg, Germany

Jean-Noël HuguesCenter for Reproductive MedicineJean Verdier HospitalUniversity Paris XIIIParis, France

Wolfgang SchulzeFertility Center HamburgHamburg, Germany

Faculty

Programme

9

Programme

Legend

E: Exchange (25’ lecture and 20’ discussion)

Friday, 23 September 2016

08.50 Registration

09.10 Opening and introduction R. Fischer (Germany)

Session I Controlled ovarian stimulation 09.35 E1 Implementing TQmS to ART clinic - Qm and Risk management in the ART Laboratory R. Fischer (Germany)

10.15 E2 The Poor Responders: Aetiology & management J.-N. Hugues (France) 11.00 Coffee break

11.15 E3 The role of LH in COS R. Fischer (Germany) 12.00 E4 Progesterone rise on triggering day-What does it mean? J.-N. Hugues (France)

12.45 Lunch

14.00 E5 Biomarkers and Pharmacogenomics: What are the new options for COS Standardisation C. Alviggi (Italy)

14:45 E6 The Poor Prognosis Patient-The “Poseidon” Subgroups and management C. Alviggi (Italy)

15.30 Coffee break

10

15.45 Case studies

Clinic and IVF-Lab visit

17:30 End of the first day

Saturday, 24 September 2016

Session II Improving ART results

09.00 E7 The Luteal Phase Support-New challenges? R. Fischer (Germany)

09.45 E8 How can andrology help optimizing ART cycles W. Schulze (Germany)

10.30 Coffee break

10.45 E9 The role of the reproductive Genetic in optimizing ART results K. Held (Germany)

11.30 E10 The Fischer’s Concept for iCOS R. Fischer (Germany) 12.15 Let’s talk

13.00 End of the course

Closing lunch

Programme

11

EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME®) and all other professional organizations, as applicable, which state that programmes awarding continuing education credits must be balanced, independent, objective and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and all programme-related materials neither imply an endorsement nor a recommendation on the part of EXCEMED. All presentations represent solely the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Carlo Alviggi Declared receipt of honoraria or consultation fees from Merck.

Robert Fischer Declared no potential conflict of interest.

Jean-Noël Hugues Declared receipt of honoraria or consultation fees from Merck. Karsten Held Receipt of honoraria by Oxford Gene Technology (OGT). CEO medical director and share-holder of Reprogenetics Germany LLC.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of 12 September 2016. Wolfgang Schulze

Disclosure of faculty relationships

12

General Information

VenueThis educational course will take place at the:Fertility Centre HamburgSpeersort 4, 20095 Hamburg, Germany

LanguageThe official language of this live educational course will be English.

CME ProviderEXCEMED - Excellence in Medical EducationSenior Programme Manager: Chloé XilinasT +39 06 420413 505 - F +39 06 420413 677chloe.xilinas@excemed.org Medical Advisor: Angelo Marinoangelo.marino@clinicaandros.it

Visitwww.excemed.org

13

Keep in touch

All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of EXCEMED. This programme is made possible thanks to an educational grant received from Merck KGaA, Darmstadt, Germany

Keep in touch

https://twitter.com/EXCEMED_Repro

www.facebook.com/excemed/

www.linkedin.com/company/excemed---excellence-in-medical-education

147

Take a look at the reproductive medicinesection of the EXCEMED website

Infertility issues have been significant in developed countries forsome time and are now becoming relevant across much of theworld. Besides being a challenging medical problem, infertility canalso have profound psychological effects, such as influencingdynamics within a couple, and affecting quality of life. Infertility alsohas ethical, social and economic implications, which have generatedheated debates among experts. Reproductive health, the branch ofmedicine concerned with infertility treatments is continuallyexploring new techniques to address the problem. Healthcareprofessionals working in this field need access to regular updatesand training.

Visit the reproductive medicine section:

www.reproductive-medicine.excemed.organd register to access free e-learning activities and receive updateson new events and resources.

12 extracts REPRODUCTIVE MEDICINE SPRING-SUMMER 2014

www.excemed.orgIt’s active in here

IMPROVING THE PATIENT’S LIFE THROUGH

MEDICAL EDUCATION

EXCEMED at your fingertips> Six specialty micro sites, including reproductive

medicine> Accessible and accredited e-learning packages> A world-class repository of CME knowledge and

learning materials > Monthly updates about our events and resources

in reproductive medicine> Register with us online and access it all – free

Better outcomes for patients start here. With over 40 years of experience, EXCEMED has been delivering continuing medical education (CME) longer than any other provider.

15

All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of EXCEMED. This independent programme is supported by independent educational grants received from Merck KGaA, Darmstadt Germany, and MVZ Fertility Center Hamburg.

Titolo provaCardio

TitoloExemed is proud to announceForum on cardiovascularexaminespecific

16

EXCEMED - Excellence in Medical EducationHeadquarters14, Rue du Rhône - 1204 Geneva, SwitzerlandRepresentative OfficeSalita di San Nicola da Tolentino 1/b - 00187 Rome, ItalyT +39 06 420413 1 - F +39 06 420413 677

Copyright © EXCEMED, 2016. All rights reserved.

Improving the patient's life through medical educationwww.excemed.org